atogepant

FDA Drug Profile

atogepant is listed in the FDA National Drug Code directory with 3 NDC codes. Available dosage form: tablet.

Drug details

Generic Name
atogepant
Sponsor
AbbVie Inc.
NDC Codes
3
Dosage Forms
TABLET
Active Ingredients
ATOGEPANT

Indications and Usage

1 INDICATIONS AND USAGE QULIPTA is indicated for the preventive treatment of migraine in adults. QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.